In other countries
The same active substances on other registers, the same brand first.
- RystiggoBrazil · Ucb Biopharma Ltda.Same brand
- Rystiggo 140 MG/ML Solucion InyectableSpain · 280 mg · solución inyectable · Ucb PharmaSame brand
- RystiggoEuropean Union · UCB PharmaSame brand
- RystiggoCroatiaSame brand
- RystiggoItaly · Soluzione iniettabile · Ucb Pharma S.A.Same brand
- Rystiggo 140 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · UCB Pharma S.A.Same brand
- RystiggoUnited States · 420MG/3ML · Injection · UCB, Inc.Same brand
- RystiggoUnited States · 280MG/2ML · injectable · Ucb INCSame brand
- RystiggoUnited States · 840MG/6ML · Injection · UCB, Inc.Same brand
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Rozanolixizumab
- Strength
- 420 MG / 3 ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Authorised
- Status in the register
- Approved
- Registration
- DIN 02567067
- Marketing authorisation holder
- Ucb Canada INC
- ATC code
- L04AL02
- Supply
- PRESCRIPTION, SCHEDULE D